Skip to content
MedsAcross

Medicine

Lansoprazole 15 mg delayed-release capsule

Lansoprazole · Oral
Available on requestPrescription onlyUS FDAGeneric name

Lansoprazole 15 mg delayed-release capsule is a generic prescription medicine for oral use, made by 16 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 25°C (77°F), excursions permitted to 15-30°C (59-86°F).

Key facts

Active ingredient (INN)
Lansoprazole
Brand
Sold under the generic name
Strength
15 mg
Dosage form
Delayed-release capsule
Route
Oral
Packs
30 capsules, 100 capsules, 90 capsules and 61 more
Manufacturers
Dr. Reddy's LaboratoriesIndiaCamber PharmaceuticalsIndiaAjanta PharmaIndiaAscend LaboratoriesIndiaLifestar PharmaIndiaMacleods PharmaceuticalsIndiaBryant Ranch PrepackNuCare Pharmaceuticals,IncMylan PharmaceuticalsTeva Pharmaceuticals16 labelers on the register
Origin register
US FDA, United States
Storage
Store at 25°C (77°F), excursions permitted to 15-30°C (59-86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
A02BC03 Lansoprazole
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
10 November 2009
Identifiers
RxCUI 596843, 311277DailyMed set ID 1c364fc5-eb43-b12f-e063-6294a90a4319, 924c5a35-4804-4e14-a2fc-2b84d186d257, c77da981-9260-fabd-e053-2a95a90aa71c +21NDC 68071-3633, 68001-111, 80425-0148 +21Application ANDA205868, ANDA091269, ANDA077255 +6

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

A sample of 40 packs from 16 labelers. The register lists 64 packs for this generic presentation, and we confirm the exact pack on the quote.

PackCodeLabelerMarketed since
30 capsule, delayed release in 1 bottle27241-019-03Ajanta PharmaIndia18 October 2016
100 capsule, delayed release in 1 bottle27241-019-10Ajanta PharmaIndia18 October 2016
30 capsule, delayed release in 1 bottle67877-274-30Ascend LaboratoriesIndia20 January 2019
90 capsule, delayed release in 1 bottle67877-274-90Ascend LaboratoriesIndia20 January 2019
100 capsule, delayed release in 1 bottle31722-570-01Camber PharmaceuticalsIndia18 May 2020
500 capsule, delayed release in 1 bottle31722-570-05Camber PharmaceuticalsIndia18 May 2020
1000 capsule, delayed release in 1 bottle31722-570-10Camber PharmaceuticalsIndia18 May 2020
30 capsule, delayed release in 1 bottle31722-570-30Camber PharmaceuticalsIndia18 May 2020
90 capsule, delayed release in 1 bottle31722-570-90Camber PharmaceuticalsIndia18 May 2020
100 capsule, delayed release in 1 bottle55111-398-01Dr. Reddy's LaboratoriesIndia15 October 2010
500 capsule, delayed release in 1 bottle55111-398-05Dr. Reddy's LaboratoriesIndia15 October 2010
30 capsule, delayed release in 1 bottle55111-398-30Dr. Reddy's LaboratoriesIndia15 October 2010
60 capsule, delayed release in 1 bottle55111-398-60Dr. Reddy's LaboratoriesIndia15 October 2010
1 blister pack in 1 carton / 10 capsule, delayed release in 1 blister pack55111-398-79Dr. Reddy's LaboratoriesIndia15 October 2010
90 capsule, delayed release in 1 bottle55111-398-90Dr. Reddy's LaboratoriesIndia15 October 2010
30 capsule, delayed release in 1 bottle70756-806-30Lifestar PharmaIndia4 June 2018
30 capsule, delayed release in 1 bottle33342-310-07Macleods PharmaceuticalsIndia5 November 2024
30 capsule, delayed release pellets in 1 bottle, plastic0378-8015-93Mylan Pharmaceuticals10 November 2009
30 capsule, delayed release in 1 bottle0093-7350-56Teva Pharmaceuticals11 November 2009
30 capsule, delayed release in 1 bottle70700-262-30Xiromed24 August 2018
60 capsule, delayed release in 1 bottle68071-2274-6NuCare Pharmaceuticals,Inc8 October 2020
14 capsule, delayed release in 1 bottle68071-2274-7NuCare Pharmaceuticals,Inc22 October 2026
14 capsule, delayed release in 1 bottle68071-2734-1NuCare Pharmaceuticals,Inc1 July 2026
60 capsule, delayed release in 1 bottle68071-2734-6NuCare Pharmaceuticals,Inc25 May 2022
30 capsule, delayed release in 1 bottle68071-3633-3NuCare Pharmaceuticals,Inc1 July 2024
30 capsule, delayed release in 1 bottle68071-3634-3NuCare Pharmaceuticals,Inc25 June 2024
30 capsule, delayed release in 1 bottle68071-3687-3NuCare Pharmaceuticals,Inc25 September 2024
60 capsule, delayed release in 1 bottle68071-4456-6NuCare Pharmaceuticals,Inc31 May 2018
30 capsule, delayed release in 1 bottle71335-0058-1Bryant Ranch Prepack2 August 2018
90 capsule, delayed release in 1 bottle71335-0058-2Bryant Ranch Prepack11 December 2020
60 capsule, delayed release in 1 bottle71335-0058-3Bryant Ranch Prepack11 April 2018
58 capsule, delayed release in 1 bottle71335-0058-4Bryant Ranch Prepack28 June 2022
28 capsule, delayed release in 1 bottle71335-0058-5Bryant Ranch Prepack28 June 2022
14 capsule, delayed release in 1 bottle71335-0058-6Bryant Ranch Prepack10 December 2019
120 capsule, delayed release in 1 bottle71335-0058-7Bryant Ranch Prepack28 June 2022
180 capsule, delayed release in 1 bottle71335-0058-8Bryant Ranch Prepack28 June 2022
30 capsule, delayed release in 1 bottle71335-2957-1Bryant Ranch Prepack28 October 2025
30 capsule, delayed release in 1 bottle71335-9680-1Bryant Ranch Prepack6 April 2023
15 capsule, delayed release in 1 bottle71335-9680-2Bryant Ranch Prepack6 April 2023
60 capsule, delayed release in 1 bottle71335-9680-3Bryant Ranch Prepack6 April 2023

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 10 May 1995Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Lansoprazole

Clinical summary

Lansoprazole is a proton pump inhibitor indicated for the treatment of active duodenal ulcer in adults, among other approved uses. It is available as delayed-release capsules, delayed-release orally disintegrating tablets and orally disintegrating tablets. MedsAcross supplies Lansoprazole for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Lansoprazole

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Lansoprazole 15 mg delayed-release capsule for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.